Cubist Systematic Strategies’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5,269
| Closed | -$490K | – | 3991 |
|
|
2021
Q4 | $490K | Sell |
5,269
-7,046
| -57% | -$464K | ﹤0.01% | 2461 |
|
|
2021
Q3 | $733K | Buy |
+12,315
| New | +$727K | 0.01% | 1763 |
|
|
2021
Q2 | – | Sell |
-8,749
| Closed | -$607K | – | 3201 |
|
|
2021
Q1 | $607K | Buy |
8,749
+6,639
| +315% | +$511K | 0.01% | 1852 |
|
|
2020
Q4 | $162K | Buy |
2,110
+1,795
| +570% | +$135K | ﹤0.01% | 2318 |
|
|
2020
Q3 | $24K | Sell |
315
-555
| -64% | -$37K | ﹤0.01% | 2407 |
|
|
2020
Q2 | $55K | Buy |
870
+300
| +53% | +$16.5K | ﹤0.01% | 2265 |
|
|
2020
Q1 | $24K | Sell |
570
-10,595
| -95% | -$486K | ﹤0.01% | 2058 |
|
|
2019
Q4 | $507K | Buy |
11,165
+10,957
| +5,268% | +$518K | 0.01% | 1548 |
|
|
2019
Q3 | $10K | Buy |
208
+108
| +108% | +$6.07K | ﹤0.01% | 2147 |
|
|
2019
Q2 | $6K | Buy |
+100
| New | +$5.17K | ﹤0.01% | 2417 |
|
|
2019
Q1 | – | Sell |
-4,022
| Closed | -$157K | – | 2484 |
|
|
2018
Q4 | $157K | Buy |
4,022
+1,739
| +76% | +$68.3K | 0.01% | 1618 |
|
|
2018
Q3 | $105K | Sell |
2,283
-17,617
| -89% | -$714K | 0.01% | 1598 |
|
|
2018
Q2 | $868K | Buy |
+19,900
| New | +$855K | 0.04% | 543 |
|
|
2018
Q1 | – | Sell |
-2,753
| Closed | -$94K | – | 2156 |
|
|
2017
Q4 | $94K | Sell |
2,753
-4,052
| -60% | -$115K | 0.01% | 1690 |
|
|
2017
Q3 | $174K | Buy |
+6,805
| New | +$156K | 0.01% | 1500 |
|
|
2015
Q4 | – | Sell |
-18,517
| Closed | -$354K | – | 2028 |
|
|
2015
Q3 | $354K | Buy |
+18,517
| New | +$629K | 0.02% | 1151 |
|
|
2015
Q1 | – | Sell |
-5,490
| Closed | -$191K | – | 2142 |
|
|
2014
Q4 | $191K | Buy |
+5,490
| New | +$223K | 0.01% | 1533 |
|
Cubist Systematic Strategies's ARNA Position: Q1 2022 in Review
Cubist Systematic Strategies sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 5,269 shares — an estimated $490K sold.
Cubist Systematic Strategies first reported a position in ARNA in Q4 2014 and held it in 17 quarters. The position peaked at $868K in Q2 2018. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Cubist Systematic Strategies reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Cubist Systematic Strategies sold 5,269 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $490K.
- Cubist Systematic Strategies first reported a position in Arena Pharmaceuticals Inc in Q4 2014 and held it in 17 quarters.
- Cubist Systematic Strategies's Arena Pharmaceuticals Inc position peaked at $868K in Q2 2018.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.